DRUG Latest Press Releases

-- November 11, 2026 --

BRIGHT MINDS BIOSCIENCES DRUG INVESTORS: Contact Kirby McInerney LLP About the Firm's Securities Investigation Following 52.3% Share Drop Business Wire 10:00 AM

-- November 9, 2026 --

Bright Minds Biosciences (DRUG) Securities Investigation Notice - Levi & Korsinsky PRNewswire 10:09 AM

-- November 5, 2026 --

Levi & Korsinsky Notifies Investors of Pending Investigation Into Securities Claims Involving Bright Minds Biosciences (DRUG) Globe Newswire 10:07 AM

-- November 4, 2026 --

BRIGHT MINDS BIOSCIENCES INVESTIGATION: DRUG Securities Investors Encouraged to Contact Kirby McInerney LLP About Their Rights Globe Newswire 2:01 PM

DRUG Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Bright Minds Biosciences (DRUG) ACCESS Newswire 10:10 AM

-- November 3, 2026 --

DRUG SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Bright Minds Biosciences PRNewswire 2:53 PM

-- November 2, 2026 --

Bright Minds Biosciences Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Bright Minds Biosciences (DRUG) PRNewswire 6:26 PM

Bright Minds Biosciences Provides Update About Planned Study with BMB-101 in Developmental and Epileptic Encephalopathies Globe Newswire 7:30 AM

-- September 30, 2026 --

Bright Minds Biosciences to Participate in the 2026 FPWR Research Symposium and PWS Family Conference Globe Newswire 5:30 PM

-- September 4, 2026 --

Bright Minds Biosciences to Present at Upcoming Conferences Globe Newswire 4:30 PM

-- July 31, 2026 --

Vistagen Appoints Douglas J. Williamson to its Board of Directors Globe Newswire 8:30 AM

Market Data Delayed 15 Minutes